Psychiatric Outcomes of Antiseizure Medications in Newly Diagnosed Focal Onset Epilepsy: From the Human Epilepsy Project Cohort Study.

Hamada Hamid Altalib; Poojith Nuthalapati; Zhiyuan Zhang; Margaret T Gopaul; Andres M Kanner; Barry E Gidal; as the HEP Investigators

doi:10.1212/cpj.0000000000200645

SCHEDA SCIENTIFICA2026Studio osservazionale

Psychiatric Outcomes of Antiseizure Medications in Newly Diagnosed Focal Onset Epilepsy: From the Human Epilepsy Project Cohort Study.

Hamada Hamid Altalib, Poojith Nuthalapati, Zhiyuan Zhang, Margaret T Gopaul, Andres M Kanner, Barry E Gidal, as the HEP Investigators

Neurology. Clinical practice · 2026

Psicoterapia Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansFemaleAnticonvulsantsMaleLevetiracetamAdultLamotrigineEpilepsies, PartialMiddle AgedCohort StudiesAdolescentMental DisordersTreatment OutcomeYoung AdultProspective StudiesSodium Channel Blockers

Come citare questo studio

Hamada Hamid Altalib, Poojith Nuthalapati, Zhiyuan Zhang, Margaret T Gopaul, Andres M Kanner, Barry E Gidal, as the HEP Investigators. (2026). Psychiatric Outcomes of Antiseizure Medications in Newly Diagnosed Focal Onset Epilepsy: From the Human Epilepsy Project Cohort Study.. Neurology. Clinical practice. DOI: 10.1212/cpj.0000000000200645

Consulta la pubblicazione originale ↗